- All
- Product Name
- Product Keyword
- Product Model
- Product Summary
- Product Description
- Multi Field Search
| Image | CAS No. | Purity | API Name | Last Drug Patent Expires | Details |
|---|---|---|---|---|---|
 | 941685-27-4 | 98%~102% | Ruxolitinib, Baricitinib | 5/5/2041 (Ruxolitinib); 11/30/2032 (Baricitinib) | View detail » |
 | 591769-05-0 | 98% min (GC) | Ruxolitinib | 5/5/2041 (Ruxolitinib) | View detail » |
 | 1146629-83-5 | 98.0% min (HPLC); 99.8% e.e min (HPLC) | Ruxolitinib | 5/5/2041 (Ruxolitinib) | View detail » |
 | 1346623-11-7 | 98% min (HPLC) | Avacopan | 5/29/2041 (Avacopan) | View detail » |
 | 1357259-88-1 | 97% min (HPLC) | Avacopan | 5/29/2041 (Avacopan) | View detail » |
 | 838-57-3 | 98% min (HPLC) | Avacopan | 5/29/2041 (Avacopan) | View detail » |
 | 3024622-70-3 | 98% min (HPLC) | View detail » | ||
 | 932710-63-9 | 98% min (HPLC) | View detail » | ||
 | 3680-69-1 | Ruxolitinib, Tofacitinib, Ritlecitinib, Baricitinib, Abrocitinib, Delgocitinib | 5/5/2041 (Ruxolitinib); 3/14/2034 (Tofacitinib); 12/3/2034 (Ritlecitinib); 11/30/2032 (Baricitinib); 2/19/2034 (Abrocitinib) | View detail » | |
 | 1672665-55-2 | 98% min (HPLC) | Belzutifan | 9/5/2034 (Belzutifan) | View detail » |
 | 2738675-96-0 | 98% min (HPLC) | Belzutifan | 9/5/2034 (Belzutifan) | View detail » |
 | 481048-22-0 | 99%+ | Eribulin | 7/8/2027 (Eribulin) | View detail » |
 | 185411-11-4 | 99% min | Eribulin | 7/8/2027 (Eribulin) | View detail » |
 | 157322-47-9 | 99% min | Eribulin | 7/8/2027 (Eribulin) | View detail » |
 | 1808153-90-3 | 99% min | Eribulin | 7/8/2027 (Eribulin) | View detail » |
 | 546141-24-6 | 99% min | Eribulin | 7/8/2027 (Eribulin) | View detail » |
 | 871348-24-2 | 99% min | Eribulin | 7/8/2027 (Eribulin) | View detail » |
 | 481048-21-9 | 99% min | Eribulin | 7/8/2027 (Eribulin) | View detail » |
 | 56069-39-7 | 98% min | Organophosphorus compounds | 7/8/2027 (Eribulin) | View detail » |
 | 871360-10-0 | 99% min | Eribulin | 7/8/2027 (Eribulin) | View detail » |
